Zuberitamab

Tax included
Zuberitamab (HS006) is a monoclonal antibody that targets CD20 and can be used in cancer research, including diffuse large B-cell lymphoma.
MedChemExpress 
HY-P99501

Data sheet

Size
Multiple sizes
Reactivity
CD20
Application
Cancer-programmed cell death
CAS
2251143-19-6